SCHEMBL12526259

SCHEMBL12526259

FC(F)(F)c1ccnc(NC2CCNC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH2 P48735 3/20 0.50
▸ PIK3CA P42336 1/20 0.50
▸ MKNK1 Q9BUB5 1/20 0.50
▸ MKNK2 Q9HBH9 1/20 0.50
▸ HRH4 Q9H3N8 1/20 0.48
▸ HRH3 Q9Y5N1 1/20 0.48
▸ SYK P43405 1/20 0.47
▸ IDH1 O75874 3/20 0.46
▸ IKBKB O14920 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ CCNT1 O60563 2/20 0.43
▸ CCNK O75909 2/20 0.43
▸ CCNE1 P24864 2/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ CDK9 P50750 2/20 0.43
▸ CDK12 Q9NYV4 2/20 0.43
▸ ADRB1 P08588 1/20 0.43
▸ PLK4 O00444 1/20 0.42
▸ CHEK1 O14757 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2243533 0.92 MAPK1 (0.55) IDH2PIK3CAMKNK1HRH4HRH3
Hydrochloric Acid SCHEMBL3775270 0.90 MAPK1 (0.53) IDH2PIK3CAMKNK1HRH4HRH3
SCHEMBL30775331 0.84 IDH1 (0.57) IDH2HRH4SYKIDH1HDAC8
SCHEMBL3808227 0.77 IDH1 (0.51) IDH2MKNK2HRH4SYKIDH1
SCHEMBL14814959 0.77 ADRB1 (0.43) IDH2SYKIDH1IKBKBHDAC8
SCHEMBL17961781 0.75 KDM4E (0.55) IDH2MKNK1MKNK2HRH4HRH3
SCHEMBL17961784 0.75 KDM4E (0.55) IDH2MKNK1MKNK2HRH4HRH3
SCHEMBL17961788 0.75 KDM4E (0.55) IDH2MKNK1MKNK2HRH4HRH3
SCHEMBL28551784 0.75 MKNK1 (0.50) IDH2MKNK1MKNK2HRH4HRH3
SCHEMBL30478386 0.74 PIK3CA (0.49) IDH2PIK3CAHRH4HRH3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012125661-A1 SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2012-09-20 — — WO disclosed
Send feedback